Incannex Healthcare Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Incannex Healthcare Inc. (IXHL) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $2.61 million for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2025-09-29
- Incannex Healthcare Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $2.61M, a 70.78% decline from fiscal 2024.
- Incannex Healthcare Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $8.93M.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|
| 2025-06-30 | $2.61M 10-K · filed 2025-09-29 |
| 2024-06-30 | $8.93M 10-K · filed 2025-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |